These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 61612)

  • 1. [Proposed practical classification of weak B phenotypes B 3, Bx, B el].
    Salmon C
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):89-104. PubMed ID: 61612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative and thermodynamic study of weak A erythrocyte phenotypes].
    Cartron JP
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):35-54. PubMed ID: 61610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative and thermodynamic study of B antigen in a family including individuals with phenotypes B 3 and AB 3].
    Chassaigne M; Lopez M; Krawczynska S; Saint-Paul B
    Rev Fr Transfus Immunohematol; 1977 Dec; 20(4):565-73. PubMed ID: 601399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Cis AB complex of the ABO system].
    Salmon C; Lopez M; Liberge G; Gerbal A
    Rev Fr Transfus Immunohematol; 1975 Mar; 18(1):11-25. PubMed ID: 1209088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and thermodynamic studies of erythrocytic ABO antigens.
    Salmon C; Lopez M; Cartron JP; Bouguerra A
    Transfusion; 1976; 16(6):580-93. PubMed ID: 996920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of IgG and IgM ABO antibodies against some weak A (A3, Ax, Aend) and weak B (B3, Bx) red cells.
    Lopez M; Benali J; Bony V; Salmon C
    Vox Sang; 1979; 37(5):281-5. PubMed ID: 524799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen site distribution among weak A' red cell populations. A study of A3, Ax and Aend variants.
    Cartron JP; Reyes F; Gourdin MF; Garretta M; Salmon CH
    Immunology; 1977 Feb; 32(2):233-44. PubMed ID: 66194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative and qualitative study of ABH antigens of cis AB blood group].
    Lopez M
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):117-26. PubMed ID: 788099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and mechanistic evaluation for the weak A phenotype in Ael blood type with IVS6 + 5G>A ABO gene mutation.
    Chen DP; Sun CF; Ning HC; Peng CT; Wang WT; Tseng CP
    Vox Sang; 2015 Jan; 108(1):64-71. PubMed ID: 25234298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Properties of alpha-N-acetylgalactosaminyltransferases in sera of group A and weak A subjects].
    Cartron JP
    Rev Fr Transfus Immunohematol; 1976 Mar; 19(1):67-88. PubMed ID: 823628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Unclassifiable" weak A blood group and deficient H phenotype (Hm) in one pedigree. Variants of A and H types in a family.
    Light J; Wenk RE; Greenwell P
    Clin Genet; 1987 Jan; 31(1):7-12. PubMed ID: 3502692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of B60 phenotype including B3 and some Bx.
    Salmon C; Liberge G; Gerbal A; Lopez M
    Biomedicine; 1974 Dec; 21(12):465-70. PubMed ID: 4462869
    [No Abstract]   [Full Text] [Related]  

  • 13. The B3 phenotype in Chinese.
    Lin-Chu M; Broadberry RE; Chiou PW
    Transfusion; 1986; 26(5):428-30. PubMed ID: 3765036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological aspects of the acquired B antigen.
    Gerbal A; Maslet C; Salmon C
    Vox Sang; 1975; 28(5):398-403. PubMed ID: 235812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic analysis of variant phenotypes of the ABO blood group system.
    Ogasawara K; Yabe R; Uchikawa M; Saitou N; Bannai M; Nakata K; Takenaka M; Fujisawa K; Ishikawa Y; Juji T; Tokunaga K
    Blood; 1996 Oct; 88(7):2732-7. PubMed ID: 8839869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mechanism of blood group (ABO)-expression.
    Yoshida A
    Acta Biol Med Ger; 1981; 40(7-8):927-41. PubMed ID: 6800172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interallelic competition and complementation in the ABO blood group system.
    Hrubisko M; Mergancová O; Prodanov P; Hammerová T; Racková M
    Immunol Commun; 1980; 9(2):139-53. PubMed ID: 7399562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the agglutination reaction in slide test for weak B blood group by gold nanoparticle solution: the first world report.
    Wiwanitkit V; Seereemaspun A; Rojanathanes R
    J Immunol Methods; 2007 Dec; 328(1-2):201-3. PubMed ID: 17936294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of anti-A and anti-B monoclonal reagents. Agglutination of some weak ABH erythrocyte variants and recognition of synthetic oligosaccharide and tissue antigens.
    Gane P; Vellayoudom J; Mollicone R; Breimer ME; Samuelsson BE; Rouger P; Gérard G; Le Pendu J; Oriol R
    Vox Sang; 1987; 53(2):117-25. PubMed ID: 2446429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative study of ABO blood group system. II. Quantitative parameters of certain weak categories of A and B agglutinogen complexes and of "Bombay" OA1h, Ah, and rare Bh phenotypes. Quantitative study of OHm, AHm and AHmB phenotypes].
    Prodanov P; Hrubisko M; Beranova G; Calkovska Z; Velvartova M; Dankova A
    Nouv Rev Fr Hematol; 1970; 10(1):31-40. PubMed ID: 4246335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.